New Covid vaccines from Pfizer , Moderna and Novavax will likely provide protection against the new "Eris" variant, now the dominant strain of the virus in the U.S.
The drugmakers designed their updated vaccines to target the omicron subvariant XBB.1.5, which is slowly declining nationwide.
Eris accounted for 17.3% of all cases in the U.S. as of earlier this month, according to the latest data from the CDC.
The World Health Organization earlier this month designated Eris a "variant of interest," meaning it will be monitored for mutations that could potentially make it more severe.
It's also not expected to cause a huge wave of Covid cases like other strains have in previous years.
Persons:
Dr, Mark Mulligan, It's
Organizations:
Chicago Department of Public Health, Southwest Senior Center, Pfizer, Moderna, U.S, EG, NYU, Vaccine, CNBC, Food and Drug Administration, Disease Control, CDC, World Health Organization
Locations:
Covid, Chicago , Illinois, Novavax, U.S